▶주메뉴 바로가기

▶본문 바로가기

THE INVESTOR
August 20, 2018
Big Reunion

Market Now

Feelux’s subsidiary to acquire US bio firm at W16.1b

  • PUBLISHED :June 12, 2018 - 14:33
  • UPDATED :June 12, 2018 - 14:33
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print
[DISCLOSURE] Feelux (033180) announced on June 12 that its subsidiary CAR-TCellKor has decided to take over 100 percent stake in US bio company Liminatus Pharma at 16.1 billion won (US$14.98 million). 

This amounts to 8.39 percent of its equity capital. 

By Hwang You-mee (glamazon@heraldcorp.com)
  • facebook
  • twitter
  • sms
  • print

EDITOR'S PICKS